Related Experiment Video
Updated: May 24, 2025

Measuring Caspase Activity Using a Fluorometric Assay or Flow Cytometry
Published on: March 24, 2023
Comprehensive analysis of the role of Caspases in glioma
Heming Wang1, Qunfang Mei2, Pengying Mei2
1Hainan Key Laboratory for Sustainable Utilization of Tropical Bioresource, Hainan University, Haikou 570228, China.
Abstract:
Caspases (CASPs) are attractive targets for cancer therapy. Many prognostic models based on gene signatures include genes from the CASPs family in diffuse glioma. CASP3, CASP4 and CASP6 in glioma have been studied individually. However, specialized comprehensive analysis of the roles of CASPs family in glioma is lacking. Therefore, this study utilized bioinformatics methods to investigate this issue. CASP1-10 expressionlevels were significantly up-regulated in LGG and GBM and glioma, and varied significantly across different clinical subgroups of glioma and LGG and various cell types, and most of CASP1-10 members showed significant differences in recurrence status of LGG. 10 signatures (CASP1-10) were associated with poor overall survival (OS) in glioma and LGG and GBM. However, pan-cancer survival analysis showed that CASP1-10 were associated with the prognosis of LGG, but not GBM. CASP1-10 were related to poor prognosis of glioma and LGG, except for CASP9, which was the opposite of a protective factor. CASP1-10 were independent prognostic factors for OS in glioma and LGG, except for CASP5, and also for recurrence-free survival (RFS) in LGG. Most of CASP1-10 were also independent prognostic factors for disease-specific survival (DSS) and progression-free interval (PFI) and had diagnostic value in glioma and LGG. Genetic alterations of CASP1-10 genes set were associated with poor prognosis in LGG. CASP1-10 were involved in immune infiltration and programmed cell death in glioma and LGG and GBM, and might promote the apoptosis of immune cells. Compared to GBM, CASP1-10 had a more significant impact on the prognosis, cancer-related pathways, and immune infiltration in LGG, indicating that CASP1-10 might play important roles in the recurrence and progression of LGG, and might be promising therapeutic targets for LGG. Therefore, it is speculated that natural caspase inhibitor p35 may be a promising drug for the treatment of glioma, especially for LGG.
Insights
Caspase family genes (CASP1-10) are upregulated in glioma and linked to poor prognosis, especially in lower-grade glioma (LGG). These genes may serve as therapeutic targets for glioma treatment.
Area of Science:
- Oncology
- Molecular Biology
- Bioinformatics
Background:
- Caspases (CASPs) are crucial in apoptosis and are implicated in various cancers.
- While individual CASP genes have been studied in glioma, a comprehensive analysis of the entire CASP family's role is lacking.
- Glioma prognosis and treatment strategies could benefit from understanding the CASP family's collective impact.
Purpose of the Study:
- To comprehensively investigate the expression, prognostic value, and functional roles of the CASP family (CASP1-10) in glioma using bioinformatics.
- To explore the potential of CASP family genes as therapeutic targets, particularly in lower-grade glioma (LGG).
Main Methods:
- Bioinformatic analysis of CASP1-10 gene expression and its correlation with clinical parameters in glioma datasets.
- Survival analysis (overall survival, recurrence-free survival, disease-specific survival, progression-free interval) was performed.
- Investigation of the association between CASP family genes, immune infiltration, and cancer-related pathways.
Main Results:
- CASP1-10 expression was significantly upregulated in glioma, including LGG and glioblastoma (GBM), and varied across clinical subgroups and cell types.
- Most CASP1-10 members were associated with poor prognosis (overall survival, recurrence) in glioma and LGG, but not consistently in GBM.
- CASP1-10 genes were identified as independent prognostic factors and showed diagnostic value, implicating them in immune infiltration and programmed cell death.
Conclusions:
- The CASP family (CASP1-10) plays a significant role in glioma progression and prognosis, particularly in LGG.
- CASP1-10 genes represent potential therapeutic targets for glioma, with natural caspase inhibitors like p35 showing promise, especially for LGG.
- Further research into CASP family's role in immune modulation and apoptosis could refine glioma treatment strategies.
More Related Videos
05:18Quantification of Immunostained Caspase-9 in Retinal Tissue
Published on: July 25, 2022
10:45Monitoring Cleaved Caspase-3 Activity and Apoptosis of Immortalized Oligodendroglial Cells using Live-cell Imaging and Cleaveable Fluorogenic-dye Substrates Following Potassium-induced Membrane Depola
Published on: January 13, 2012
Related Concept Videos
Caspases
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The Intrinsic Apoptotic Pathway